• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

缺血性脑卒中的细胞死亡通路与靶向药物治疗。

Cell Death Pathways in Ischemic Stroke and Targeted Pharmacotherapy.

机构信息

Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research (NIPER), Ahmedabad, Gandhinagar, Gujarat, 382355, India.

Cellular and Molecular Neurobiology Laboratory, Department of Life Science and Bioinformatics, Assam University, Silchar, Assam, India.

出版信息

Transl Stroke Res. 2020 Dec;11(6):1185-1202. doi: 10.1007/s12975-020-00806-z. Epub 2020 Mar 26.

DOI:10.1007/s12975-020-00806-z
PMID:32219729
Abstract

Ischemic stroke is one of the significant causes of morbidity and mortality, affecting millions of people across the globe. Cell injury in the infarct region is an inevitable consequence of focal cerebral ischemia. Subsequent reperfusion exacerbates the harmful effect and increases the infarct volume. These cellular injuries follow either a regulated pathway involving tightly structured signaling cascades and molecularly defined effector mechanisms or a non-regulated pathway, also known as accidental cell death, where the process is biologically uncontrolled. Classical cell death pathways are long established and well reported in several articles that majorly define apoptotic cell death. A recent focus on cell death study also considers investigation on non-classical pathways that are tightly regulated, may or may not involve caspases, but non-apoptotic. Pathological cell death is a cardinal feature of different neurodegenerative diseases. Although ischemia cannot be classified as a neurodegenerative disease, it is a cerebrovascular event where the infarct region exhibits aberrant cell death. Over the past few decades, several therapeutic options have been implicated for ischemic stroke. However, their use has been hampered owing to the number of limitations that they possess. Ischemic penumbral neurons undergo apoptosis and become dysfunctional; however, they are salvageable. Thus, understanding the role of different cell death pathways is crucial to aid in the modern treatment of protecting apoptotic neurons.

摘要

缺血性脑卒中是发病率和死亡率的主要原因之一,影响着全球数以百万计的人群。梗死区域的细胞损伤是局灶性脑缺血的必然后果。随后的再灌注会加剧这种有害影响,增加梗死体积。这些细胞损伤要么遵循受调控的途径,涉及紧密构建的信号级联和分子定义的效应机制,要么遵循非受调控的途径,也称为意外细胞死亡,其中过程是生物不受控的。经典的细胞死亡途径在多篇文章中已经确立并得到广泛报道,这些文章主要定义了细胞凋亡。最近对细胞死亡研究的关注还考虑了对受紧密调控的非经典途径的研究,这些途径可能涉及或不涉及半胱天冬酶,但非凋亡。病理性细胞死亡是多种神经退行性疾病的主要特征。尽管缺血不能被归类为神经退行性疾病,但它是一种脑血管事件,其中梗死区域表现出异常的细胞死亡。在过去的几十年中,已经提出了几种治疗缺血性脑卒中的方法。然而,由于它们存在许多限制,其应用受到了阻碍。缺血半影区的神经元经历细胞凋亡并变得功能失调;然而,它们是可挽救的。因此,了解不同细胞死亡途径的作用对于帮助现代治疗中保护凋亡神经元至关重要。

相似文献

1
Cell Death Pathways in Ischemic Stroke and Targeted Pharmacotherapy.缺血性脑卒中的细胞死亡通路与靶向药物治疗。
Transl Stroke Res. 2020 Dec;11(6):1185-1202. doi: 10.1007/s12975-020-00806-z. Epub 2020 Mar 26.
2
Regulated necrosis pathways: a potential target for ischemic stroke.程序性坏死途径:缺血性中风的潜在靶点。
Burns Trauma. 2023 Nov 18;11:tkad016. doi: 10.1093/burnst/tkad016. eCollection 2023.
3
Mechanisms of neuronal cell death in ischemic stroke and their therapeutic implications.缺血性脑卒中神经元细胞死亡的机制及其治疗意义。
Med Res Rev. 2022 Jan;42(1):259-305. doi: 10.1002/med.21817. Epub 2021 May 6.
4
Emerging Role of Ferroptosis in the Pathogenesis of Ischemic Stroke: A New Therapeutic Target?铁死亡在缺血性脑卒中发病机制中的新作用:新的治疗靶点?
ASN Neuro. 2021 Jan-Dec;13:17590914211037505. doi: 10.1177/17590914211037505.
5
[Research progress of the impacts of acupuncture on programmed cell death in treatment of ischemic stroke].针刺对缺血性脑卒中程序性细胞死亡影响的研究进展
Zhen Ci Yan Jiu. 2023 Jul 25;48(7):713-7. doi: 10.13702/j.1000-0607.20220404.
6
miRNAs-19b, -29b-2* and -339-5p show an early and sustained up-regulation in ischemic models of stroke.微小RNA-19b、-29b-2*和-339-5p在缺血性中风模型中呈现早期且持续的上调。
PLoS One. 2013 Dec 20;8(12):e83717. doi: 10.1371/journal.pone.0083717. eCollection 2013.
7
Early Reperfusion Following Ischemic Stroke Provides Beneficial Effects, Even After Lethal Ischemia with Mature Neural Cell Death.缺血性脑卒中后早期再灌注可提供有益效果,即使在成熟神经细胞死亡的致死性缺血后也是如此。
Cells. 2020 Jun 1;9(6):1374. doi: 10.3390/cells9061374.
8
The molecular machinery of regulated cell death.调控细胞死亡的分子机制。
Cell Res. 2019 May;29(5):347-364. doi: 10.1038/s41422-019-0164-5. Epub 2019 Apr 4.
9
Ischemic-hypoxic preconditioning enhances the mitochondrial function recovery of transplanted olfactory mucosa mesenchymal stem cells via miR-181a signaling in ischemic stroke.缺血缺氧预处理通过 miR-181a 信号增强移植嗅黏膜间充质干细胞在缺血性脑卒中后的线粒体功能恢复。
Aging (Albany NY). 2021 Apr 4;13(8):11234-11256. doi: 10.18632/aging.202807.
10
Neuronal injuries in cerebral infarction and ischemic stroke: From mechanisms to treatment (Review).脑梗死和缺血性脑卒中的神经元损伤:从机制到治疗(综述)。
Int J Mol Med. 2022 Feb;49(2). doi: 10.3892/ijmm.2021.5070. Epub 2021 Dec 8.

引用本文的文献

1
Dynamic mechanisms and targeted interventions in cerebral ischemia-reperfusion injury: pathological cascade from ischemia to reperfusion and promising therapeutic strategies.脑缺血再灌注损伤的动态机制及靶向干预:从缺血到再灌注的病理级联反应及有前景的治疗策略
Front Neurosci. 2025 Aug 18;19:1649533. doi: 10.3389/fnins.2025.1649533. eCollection 2025.
2
Mesenchymal stem cell-derived extracellular vesicles: current advances in preparation and therapeutic applications for neurological disorders.间充质干细胞衍生的细胞外囊泡:神经系统疾病制备与治疗应用的当前进展
Front Cell Dev Biol. 2025 Aug 18;13:1626996. doi: 10.3389/fcell.2025.1626996. eCollection 2025.
3
Exosomal circ_0093708 as a potential ferroptosis biomarker in cerebral ischemia-reperfusion injury.
外泌体circ_0093708作为脑缺血再灌注损伤中潜在的铁死亡生物标志物
Front Neurol. 2025 Aug 1;16:1633393. doi: 10.3389/fneur.2025.1633393. eCollection 2025.
4
Cerebral ischemia-reperfusion injury: mechanisms and promising therapies.脑缺血再灌注损伤:机制与前景广阔的治疗方法
Front Pharmacol. 2025 Jul 16;16:1613464. doi: 10.3389/fphar.2025.1613464. eCollection 2025.
5
Macrophage-mimetic liposomes co-delivering ceria and Ac2-26 peptide for penumbra protection in ischemic stroke.共递送二氧化铈和Ac2-26肽的巨噬细胞模拟脂质体用于缺血性中风半暗带保护
J Nanobiotechnology. 2025 Jul 5;23(1):488. doi: 10.1186/s12951-025-03575-9.
6
Emerging Targeted Delivery Strategies of Nanosystems for Ischemic Stroke Treatment.用于缺血性中风治疗的纳米系统新兴靶向递送策略
Int J Nanomedicine. 2025 Jun 24;20:8143-8171. doi: 10.2147/IJN.S519328. eCollection 2025.
7
Decoding ferroptosis in ischemic stroke: key genes and the therapeutic potential of acupuncture.解读缺血性中风中的铁死亡:关键基因与针灸的治疗潜力
Front Aging Neurosci. 2025 Jun 9;17:1506276. doi: 10.3389/fnagi.2025.1506276. eCollection 2025.
8
Exploring NMDAR pathways in ischemic stroke: implications for neurotoxic and neuroprotective mechanisms and therapeutic strategies.探索缺血性卒中中的NMDAR通路:对神经毒性和神经保护机制及治疗策略的影响
Naunyn Schmiedebergs Arch Pharmacol. 2025 Jun 10. doi: 10.1007/s00210-025-04357-8.
9
Innovative approaches for the treatment of stroke: a recent update.中风治疗的创新方法:近期进展
Naunyn Schmiedebergs Arch Pharmacol. 2025 May 29. doi: 10.1007/s00210-025-04288-4.
10
Full-spectrum Cannabis sativa extract enhances gut-peripheral organ integrity after experimental ischemic stroke.全谱大麻提取物可增强实验性缺血性中风后肠道与外周器官的完整性。
Inflammopharmacology. 2025 May 19. doi: 10.1007/s10787-025-01775-1.